These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2191850)

  • 1. Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia.
    Monk JP; Benfield P
    Drugs; 1990 May; 39(5):741-56. PubMed ID: 2191850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine.
    Golden JA; Chernoff D; Hollander H; Feigal D; Conte JE
    Lancet; 1989 Mar; 1(8639):654-7. PubMed ID: 2564468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers.
    Thomas SH; O'Doherty MJ; Page CJ; Nunan TO; Bateman NT
    Eur Respir J; 1991 May; 4(5):616-22. PubMed ID: 1936233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
    Miller RF; Godfrey-Faussett P; Semple SJ
    Thorax; 1989 Jul; 44(7):565-9. PubMed ID: 2788936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and effects on pulmonary function tests of weekly 600 mg aerosol pentamidine as prophylaxis against Pneumocystis carinii pneumonia.
    Ong EL; Dunbar EM; Mandal BK
    Infection; 1992; 20(3):136-9. PubMed ID: 1353750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pentamidine inhalation for Pneumocystis carinii pneumonia in AIDS].
    Pines A; Giladi M; Moshkowitz M; Finkelstein A; Levo Y
    Harefuah; 1989 Mar; 116(6):311-2. PubMed ID: 2786489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.
    Hirschel B; Lazzarin A; Chopard P; Opravil M; Furrer HJ; Rüttimann S; Vernazza P; Chave JP; Ancarani F; Gabriel V
    N Engl J Med; 1991 Apr; 324(16):1079-83. PubMed ID: 2008181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial.
    Conte JE; Chernoff D; Feigal DW; Joseph P; McDonald C; Golden JA
    Ann Intern Med; 1990 Aug; 113(3):203-9. PubMed ID: 2197911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased efficacy of inhaled pentamidine in the prevention of Pneumocystis carinii pneumonia among HIV-infected patients with severe immunodeficiency.
    Casale L; Gold H; Schechter C; Naficy A; Masci JR
    Chest; 1993 Feb; 103(2):342-4. PubMed ID: 8094333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical presentations of Pneumocystis carinii pneumonia in patients receiving inhaled pentamidine prophylaxis.
    Edelstein H; McCabe RE
    Chest; 1990 Dec; 98(6):1366-9. PubMed ID: 2245676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosol therapy in AIDS.
    Newman SP; Simonds AK
    Lung; 1990; 168 Suppl():685-91. PubMed ID: 2117180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. A randomized trial.
    Soo Hoo GW; Mohsenifar Z; Meyer RD
    Ann Intern Med; 1990 Aug; 113(3):195-202. PubMed ID: 2197910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolised pentamidine for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.
    Weinberg A; Dantonio SA; Duarte MI; Pedreira Júnior WL; Barone AA; Ishioka S
    Rev Inst Med Trop Sao Paulo; 1990; 32(4):289-95. PubMed ID: 2101523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia.
    Goa KL; Campoli-Richards DM
    Drugs; 1987 Mar; 33(3):242-58. PubMed ID: 3552596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia.
    Drake S; Lampasona V; Nicks HL; Schwarzmann SW
    Clin Pharm; 1985; 4(5):507-16. PubMed ID: 3902329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivered dose and regional distribution of aerosolized pentamidine using different delivery systems.
    Ilowite JS; Baskin MI; Sheetz MS; Abd AG
    Chest; 1991 May; 99(5):1139-44. PubMed ID: 2019169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An Italian multicentric randomised controlled trial. The Italian PCP Study Group.
    Rizzardi GP; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
    J Infect; 1995 Sep; 31(2):99-105. PubMed ID: 8666860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary deposition of aerosolised pentamidine using a new nebuliser: efficiency measurements in vitro and in vivo.
    Ferretti PP; Versari A; Gafà SI; Becquemin MH; Barchi E; Serafini D; Roy M; Salvo D; Bouchikhi A
    Eur J Nucl Med; 1994 May; 21(5):399-406. PubMed ID: 8062844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.